Gilead Sciences Inc (NYSE:GILD) over-valued by 21%
| Website | https://www.gilead.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $85,911,330,816 |
| Beta | 0.39893 |
| Average Volume | $7,741,875 |
| Last Dividend | 2.75% |
| Price on Nov 2, 2022 | $79.46 |
| Autochartist™ Valuation | $62.96 |
| Conclusion |
21% over-valued |
| Download Report |
